Edition #3 | November 2023
A message from our Senior Conference Producer
The womenâs health landscape has taken a notable shift in its approach towards growth amid a challenging quarter, ramping up its rhetoric that investing, innovating and prioritizing womenâs health makes economic sense in order to move the needle. With the market in a state of evolving maturity, itâs clear that womenâs health is not immune to the challenges facing the broader healthcare landscape. Despite this, there is much to look forward to in an industry that continues to highlight the economic impact of championing womenâs health, demonstrating that the market size estimate of $63.02 billion USD by 2030 is certainly within reach. In thinking about the business case for womenâs health, a theme - or rather a call-to-action - spoken about widely over the past few months, itâs important to adopt a multi-pronged approach when putting forward the âcaseâ.
The World Economic Forum has outlined that âan estimated $300 million investment into research focused on women could yield a $13 billion economic return and lead to reduced healthcare costs, better quality of life, and years of productivity returned to the global workforceâ. Furthermore, the Innovation Forum, sponsored by the Bill and Melinda Gates Foundation and the US National Institutes of Health recently published the âWomenâs Health Innovation Opportunity Map 2023â, whilst Roche Pharmaceuticals provided their insights into the business case for womenâs health... Continue reading